Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Cited by CrossRef (104)

  1. Gábor Ternák, Dániel Kuti, Krisztina J. Kovács. Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics. Medical Hypotheses 2020;137:109564
    https://doi.org/10.1016/j.mehy.2020.109564
  2. Duygu Ağagündüz, Feray Gençer Bingöl, Elif Çelik, Özge Cemali, Çiler Özenir, Fatih Özoğul, Raffaele Capasso. Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions. J Transl Med 2022;20
    https://doi.org/10.1186/s12967-022-03609-y
  3. Reza Shirazinia, Ali Akbar Golabchifar, Mohammad Reza Fazeli. Efficacy of probiotics for managing infantile colic due to their anti-inflammatory properties: a meta-analysis and systematic review. Clin Exp Pediatr 2021;64:642
    https://doi.org/10.3345/cep.2020.01676
  4. Sephira Ryman, Andrei A. Vakhtin, Sarah Pirio Richardson, Henry C. Lin. Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases. J Neurol 2023;270:746
    https://doi.org/10.1007/s00415-022-11461-9
  5. Haiyang Yu, Tong Sun, Xin He, Zhen Wang, Kaidong Zhao, Jing An, Lulu Wen, Jia-Yi Li, Wen Li, Juan Feng. Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment. Aging and disease 2022;13:1591
    https://doi.org/10.14336/AD.2022.0325
  6. Ga Hee Kim, Yeong Chan Lee, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim. Risk of Neurodegenerative Diseases in Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study. 2022;16:436
    https://doi.org/10.1093/ecco-jcc/jjab162
  7. Tahira Farooqui. Gut Microbiota in Neurologic and Visceral Diseases. 2022.
    https://doi.org/10.1016/B978-0-12-821039-0.00008-3
  8. Shen-Yuan Zheng, Hai-Xia Li, Rui-Chen Xu, Wen-Teng Miao, Ming-Yuan Dai, Song-Tao Ding, Han-Deng Liu. Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Research Reviews 2021;69:101347
    https://doi.org/10.1016/j.arr.2021.101347
  9. Sourav De, Yung-Chih Kuo. Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease. Journal of the Taiwan Institute of Chemical Engineers 2024;157:105401
    https://doi.org/10.1016/j.jtice.2024.105401
  10. Rahul Jena, Ruchi Jain, Suchitra Muralidharan, Vijaya Lakshmi Yanamala, Zainab Zubair, Ketan Kantamaneni, Krishi Jalla, Mahvish Renzu, Michael Alfonso. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson’s Disease. 2021
    https://doi.org/10.7759/cureus.19035
  11. Feiqi Zhu, Chunrong Li, Fengna Chu, Xiaoping Tian, Jie Zhu. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease. Front. Aging Neurosci. 2020;12
    https://doi.org/10.3389/fnagi.2020.544235
  12. Emily Knight, Thangiah Geetha, Donna Burnett, Jeganathan Ramesh Babu. The Role of Diet and Dietary Patterns in Parkinson’s Disease. Nutrients 2022;14:4472
    https://doi.org/10.3390/nu14214472
  13. Chong Chen, Liyu Chen, Dayong Sun, Cailan Li, Shiheng Xi, Shihua Ding, Rongrong Luo, Yan Geng, Yang Bai. Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis. Gut Pathog 2022;14
    https://doi.org/10.1186/s13099-022-00491-3
  14. Rebecca Kerstens, Paul Joyce. The Gut Microbiome as a Catalyst and Emerging Therapeutic Target for Parkinson’s Disease: A Comprehensive Update. Biomedicines 2024;12:1738
    https://doi.org/10.3390/biomedicines12081738
  15. Huijia Yang, Song Li, Weidong Le. Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease. Aging and disease 2022;13:1381
    https://doi.org/10.14336/AD.2022.01281
  16. Ho-Su Lee, Evy Lobbestael, Séverine Vermeire, João Sabino, Isabelle Cleynen. Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links. Gut 2020:gutjnl-2020-322429
    https://doi.org/10.1136/gutjnl-2020-322429
  17. Manon Defaye, Sandie Gervason, Christophe Altier, Jean-Yves Berthon, Denis Ardid, Edith Filaire, Frédéric Antonio Carvalho. Microbiota: a novel regulator of pain. J Neural Transm 2020;127:445
    https://doi.org/10.1007/s00702-019-02083-z
  18. Julio Plaza-Díaz, Patricio Solís-Urra, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Miguel Navarro-Oliveros, Francisco Abadía-Molina, Ana I. Álvarez-Mercado. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. IJMS 2020;21:8351
    https://doi.org/10.3390/ijms21218351
  19. Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model. Front. Aging Neurosci. 2023;14
    https://doi.org/10.3389/fnagi.2022.986127
  20. Michelle Ren, Shahrdad Lotfipour. The role of the gut microbiome in opioid use. 2020;31:113
    https://doi.org/10.1097/FBP.0000000000000538
  21. Jacek Karczewski, Aleksandra Zielińska, Rafał Staszewski, Piotr Eder, Agnieszka Dobrowolska, Eliana B. Souto. Obesity and the Brain. IJMS 2022;23:6145
    https://doi.org/10.3390/ijms23116145
  22. Lanxia Meng, Congcong Liu, Yiming Li, Guiqin Chen, Min Xiong, Ting Yu, Lina Pan, Xingyu Zhang, Lingyan Zhou, Tao Guo, Xin Yuan, Chaoyang Liu, Zhaohui Zhang, Zhentao Zhang. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease. Sci. Adv. 2023;9
    https://doi.org/10.1126/sciadv.adj1092
  23. Adela Dănău, Laura Dumitrescu, Antonia Lefter, Delia Tulbă, Bogdan Ovidiu Popescu. Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease. IJMS 2021;22:11663
    https://doi.org/10.3390/ijms222111663
  24. Abdolreza Norouzy, Maryam Mohamadinarab, Hamed Mirzaei Ghazi Kalayeh. Diet and Nutrition in Neurological Disorders. 2021.
    https://doi.org/10.1016/B978-0-323-89834-8.00046-5
  25. Poulomi Das, Raksha Banka, Joyeta Ghosh, Khusboo Singh, Sudrita Roy Choudhury, Samarpita Koner. Nutrition Controversies and Advances in Autoimmune Disease. 2021.
    https://doi.org/10.4018/979-8-3693-5528-2.ch006
  26. Ashwin Rajeev, Indranil Chattopadhyay. Gut Microbiome and Brain Ageing. 2021.
    https://doi.org/10.1007/978-981-99-8803-7_13
  27. Albert Pinhasov, Elena Shmerkin, Michael Kirby. Autoimmune Disorders. 2021.
    https://doi.org/10.1002/9781119858430.ch24
  28. Inga Peter, Warren Strober. Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease. JPD 2023;13:279
    https://doi.org/10.3233/JPD-230021
  29. Xueling Zhu, Bo Li, Pengcheng Lou, Tingting Dai, Yang Chen, Aoxiang Zhuge, Yin Yuan, Lanjuan Li. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neurosci. Bull. 2021;37:1510
    https://doi.org/10.1007/s12264-021-00730-8
  30. Sara Molaaghaee‐Rouzbahani, Nastaran Asri, Somayeh Jahani‐Sherafat, Davar Amani, Andrea Masotti, Kaveh Baghaei, Abbas Yadegar, Hamed Mirjalali, Mohammad Rostami‐Nejad. The modulation of macrophage subsets in celiac disease pathogenesis. Immunity Inflam & Disease 2022;10
    https://doi.org/10.1002/iid3.741
  31. R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673
    https://doi.org/10.1038/s41575-020-0339-z
  32. Marthinus Janse van Vuuren, Theodore Albertus Nell, Jonathan Ambrose Carr, Douglas B. Kell, Etheresia Pretorius. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease. Biomolecules 2020;11:30
    https://doi.org/10.3390/biom11010030
  33. Daiana Perez Visñuk, Graciela Savoy de Giori, Jean Guy LeBlanc, Alejandra de Moreno de LeBlanc. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model. Nutrition 2020;79-80:110995
    https://doi.org/10.1016/j.nut.2020.110995
  34. Sara Ayman Moustafa, Shrouk Mohamed, Abdelhameed Dawood, Jihan Azar, Ekramy Elmorsy, Noura A. M. Rizk, Mohamed Salama. Gut brain axis: an insight into microbiota role in Parkinson’s disease. Metab Brain Dis 2021;36:1545
    https://doi.org/10.1007/s11011-021-00808-2
  35. Gianfranco Natale, Larisa Ryskalin, Gabriele Morucci, Gloria Lazzeri, Alessandro Frati, Francesco Fornai. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease. Life 2021;11:732
    https://doi.org/10.3390/life11080732
  36. Bilal El-Mansoury, Kamal Smimih, Abdelaati El Khiat, Hanane El Fatimi, Abdelmohcine Aimrane, Soraia El Baz, Abdessamad Elmourid, Fatima Ez-Zahraa Saad, Hafida El Ghachi, Manal Khanouchi, Arumugam Radhakrishnan Jayakumar, Abdeljalil Zoubadi. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. 2021.
    https://doi.org/10.4018/978-1-6684-5156-4.ch017
  37. Shahrul Azmin, Rufaidah Md Rani, Norlinah Mohamed Ibrahim. Role of Micronutrients in Brain Health. 2021.
    https://doi.org/10.1007/978-981-16-6467-0_9
  38. Heng Chi, Yunqian Guan, Fengyan Li, Zhiguo Chen. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson’s Disease Model. Cell Transplant 2019;28:87S
    https://doi.org/10.1177/0963689719891134
  39. Vinod Metta, Valentina Leta, Kandadai Rukmini Mrudula, L. K. Prashanth, Vinay Goyal, Rupam Borgohain, Guy Chung-Faye, K. Ray Chaudhuri. Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol 2022;269:1154
    https://doi.org/10.1007/s00415-021-10567-w
  40. Lyudmila P. Dolgacheva, Valery P. Zinchenko, Nikolay V. Goncharov. Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease. IJMS 2022;23:13043
    https://doi.org/10.3390/ijms232113043
  41. Yixuan Liang, Li Cui, Jiguo Gao, Mingqin Zhu, Ying Zhang, Hong-Liang Zhang. Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment. Mol Neurobiol 2021;58:3745
    https://doi.org/10.1007/s12035-021-02375-0
  42. Ankita Singh, Om Prakash Verma, Rajavashisth Tripathi. Gut Microbiome in Neurological Health and Disorders. 2021.
    https://doi.org/10.1007/978-981-19-4530-4_6
  43. Benjamin Rosen, Alberim Kurtishi, Gonzalo R. Vazquez-Jimenez, Simon Geir Møller. The Intersection of Parkinson’s Disease, Viral Infections, and COVID-19. Mol Neurobiol 2021;58:4477
    https://doi.org/10.1007/s12035-021-02408-8
  44. Yuanjie Sun, Yoshihisa Koyama, Shoichi Shimada. Measurement of intraluminal pH changes in the gastrointestinal tract of mice with gastrointestinal diseases. Biochemical and Biophysical Research Communications 2022;620:129
    https://doi.org/10.1016/j.bbrc.2022.06.061
  45. Meenakshi Kandpal, Omkar Indari, Budhadev Baral, Shweta Jakhmola, Deeksha Tiwari, Vasundhra Bhandari, Rajan Kumar Pandey, Kiran Bala, Avinash Sonawane, Hem Chandra Jha. Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites 2022;12:1064
    https://doi.org/10.3390/metabo12111064
  46. Bilal Ahmad Paray, Mohammed Fahad Albeshr, Arif Tasleem Jan, Irfan A. Rather. Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State. IJMS 2020;21:9770
    https://doi.org/10.3390/ijms21249770
  47. Anastazja M. Gorecki, Megan C. Bakeberg, Frances Theunissen, Jade E. Kenna, Madison E. Hoes, Abigail L. Pfaff, P. Anthony Akkari, Sarah A. Dunlop, Sulev Kõks, Frank L. Mastaglia, Ryan S. Anderton. Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease. Front. Aging Neurosci. 2020;12
    https://doi.org/10.3389/fnagi.2020.603849
  48. Ali Kiasat, Susanne Rautiainen, Stefanie Prast-Nielsen, Lars Engstrand, Ina Schuppe-Koistinen, Ulf O. Gustafsson, Anna Löf Granström. Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2023;58:1246
    https://doi.org/10.1080/00365521.2023.2219357
  49. Anamaria Jurcau, Felicia Liana Andronie-Cioara, Delia Carmen Nistor-Cseppento, Nicoleta Pascalau, Marius Rus, Elisabeta Vasca, Maria Carolina Jurcau. The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease. IJMS 2023;24:14582
    https://doi.org/10.3390/ijms241914582
  50. Anastazja M. Gorecki, Sarah A. Dunlop, Jennifer Rodger, Ryan S. Anderton. The gut-brain axis and gut inflammation in Parkinson’s disease: stopping neurodegeneration at the toll gate. Expert Opinion on Therapeutic Targets 2020;24:601
    https://doi.org/10.1080/14728222.2020.1763956
  51. Magda L. Atilano, Alexander Hull, Catalina-Andreea Romila, Mirjam L. Adams, Jacob Wildfire, Enric Ureña, Miranda Dyson, Jorge Ivan-Castillo-Quan, Linda Partridge, Kerri J. Kinghorn, Gregory P. Copenhaver. Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease. PLoS Genet 2023;19:e1011063
    https://doi.org/10.1371/journal.pgen.1011063
  52. Nina Gu, Jin Yan, Wei Tang, Zhaosi Zhang, Lin Wang, Zhao Li, Yingwen Wang, Yajun Zhu, Shuang Tang, Jianjun Zhong, Chongjie Cheng, Xiaochuan Sun, Zhijian Huang. Prevotella copri transplantation promotes neurorehabilitation in a mouse model of traumatic brain injury. J Neuroinflammation 2024;21
    https://doi.org/10.1186/s12974-024-03116-5
  53. Júlio César Claudino dos Santos, Micael Porto Portela Lima, Gerly Anne de Castro Brito, Glauce Socorro de Barros Viana. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis. Ageing Research Reviews 2023;84:101812
    https://doi.org/10.1016/j.arr.2022.101812
  54. A. V. Stavrovskaya, V. N. Danilenko, D. N. Voronkov, A. S. Gushchina, M. V. Marsova, A. S. Olshansky, N. G. Yamshikova, S. N. Illarioshkin. Pharmabiotic Based on Lactobacillus fermentum Strain U-21 Modulates the Toxic Effect of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine as Parkinsonism Inducer in Mice. Hum Physiol 2021;47:891
    https://doi.org/10.1134/S0362119721080120
  55. Marina Lorente-Picón, Ariadna Laguna. New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433
    https://doi.org/10.3390/biom11030433
  56. Khairiah Razali, Khaled Algantri, Su Peng Loh, Shi-Hui Cheng, Wael Mohamed. Integrating nutriepigenomics in Parkinson’s disease management: New promising strategy in the omics era. IBRO Neuroscience Reports 2022;13:364
    https://doi.org/10.1016/j.ibneur.2022.10.003
  57. Jinchuan Zhao, Xin Gao, Liangyou Zhao, Yiqing Wang, Jingbo Zhang, Shumin Liu, Weidong Pan. Effects of Cannabidiol on Parkinson’s Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1
    https://doi.org/10.1155/2022/1525113
  58. Robert Krikorian, Wilhelmina Kalt, Jane E. McDonald, Marcelle D. Shidler, Suzanne S. Summer, Amanda L. Stein. Cognitive performance in relation to urinary anthocyanins and their flavonoid-based products following blueberry supplementation in older adults at risk for dementia. Journal of Functional Foods 2020;64:103667
    https://doi.org/10.1016/j.jff.2019.103667
  59. Chien-Tai Hong, Jia-Hung Chen, Tsai-Wei Huang. Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials. Aging 2022;14:7014
    https://doi.org/10.18632/aging.204266
  60. Timm J. Filler, Sara V. Schnettler, Michael Wolf-Vollenbröker. Vegetative Innervation des Abdomens: Immunsystem, Schmerz, Mikrobiom. AkupunkturPraxis 2022;3:207
    https://doi.org/10.1055/a-1854-7008
  61. Joshua D. Elford, Nanette Becht, Johan Garssen, Aletta D. Kraneveld, Paula Perez-Pardo. Buty and the beast: the complex role of butyrate in Parkinson’s disease. Front. Pharmacol. 2024;15
    https://doi.org/10.3389/fphar.2024.1388401
  62. Kate Matthews, Timothy Cavagnaro, Philip Weinstein, Jessica Stanhope. Health by design; optimising our urban environmental microbiomes for human health. Environmental Research 2024;257:119226
    https://doi.org/10.1016/j.envres.2024.119226
  63. Shengzhu Huang, Chenqi Zhang, Xing Xie, Yuanyuan Zhu, Qiong Song, Li Ye, Yanling Hu. GRID2 aberration leads to disturbance in neuroactive ligand-receptor interactions via changes to the species richness and composition of gut microbes. Biochemical and Biophysical Research Communications 2022;631:9
    https://doi.org/10.1016/j.bbrc.2022.09.006
  64. Laura E. McCoubrey, Hannah Batchelor, Abdul W. Basit, Simon Gaisford, Mine Orlu. Biopharmaceutics. 2022.
    https://doi.org/10.1002/9781119678366.ch17
  65. Parisa Gazerani. Probiotics for Parkinson’s Disease. IJMS 2019;20:4121
    https://doi.org/10.3390/ijms20174121
  66. James K. Pru. Differences in gut microbiota observed in premenopausal and postmenopausal women associate with HIV infection status. 2021;28:480
    https://doi.org/10.1097/GME.0000000000001770
  67. Tuba Shahid Chaudhry, Sidhartha Gautam Senapati, Srikanth Gadam, Hari Priya Sri Sai Mannam, Hima Varsha Voruganti, Zainab Abbasi, Tushar Abhinav, Apurva Bhavana Challa, Namratha Pallipamu, Niharika Bheemisetty, Shivaram P. Arunachalam. The Impact of Microbiota on the Gut–Brain Axis: Examining the Complex Interplay and Implications. JCM 2023;12:5231
    https://doi.org/10.3390/jcm12165231
  68. Luisa Seguella, Brian D. Gulbransen. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol 2021;18:571
    https://doi.org/10.1038/s41575-021-00423-7
  69. Shengzhu Huang, Chenqi Zhang, Xing Xie, Yuanyuan Zhu, Qiong Song, Li Ye, Yan-Ling Hu. GRID2 Aberration Leads to Disturbance in Neuroactive Ligand-Receptor Interaction via Affecting the Species Richness and Composition of the Gut Microbes. SSRN Journal 2022
    https://doi.org/10.2139/ssrn.4133779
  70. Alexander Hull, Magda L. Atilano, Laith Gergi, Kerri J. Kinghorn. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery. Phil. Trans. R. Soc. B 2024;379
    https://doi.org/10.1098/rstb.2022.0381
  71. Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio. Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxidative Medicine and Cellular Longevity 2020;2020:1
    https://doi.org/10.1155/2020/4518023
  72. Dipita Bhattacharyya, Anirban Bhunia. Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide. Chemistry and Physics of Lipids 2021;235:105029
    https://doi.org/10.1016/j.chemphyslip.2020.105029
  73. Lorena Ortega Moreno, Ana Bagues, Vicente Martínez, Raquel Abalo. New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics. Nutrients 2023;15:2775
    https://doi.org/10.3390/nu15122775
  74. Emanuel Vamanu, Sachchida Nand Rai. The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis. Diseases 2021;9:45
    https://doi.org/10.3390/diseases9030045
  75. Meenakshi Kandpal, Nidhi Varshney, Kunal Sameer Rawal, Hem Chandra Jha. Immunology for Engineers. 2021.
    https://doi.org/10.1016/bs.apcsb.2024.02.001
  76. Agata Mulak. An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?. Expert Review of Neurotherapeutics 2020;20:127
    https://doi.org/10.1080/14737175.2020.1701437
  77. Camila Fontoura Acosta Ribeiro, Gislaine Greice de Oliveira Silva Silveira, Elizabete de Souza Cândido, Marlon Henrique Cardoso, Cristiano Marcelo Espínola Carvalho, Octávio Luiz Franco. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health. ACS Infect. Dis. 2020;6:2544
    https://doi.org/10.1021/acsinfecdis.0c00036
  78. Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, Pieter Van Den Abbeele, Arnout Bruggeman, Jawal Said, Barry Smith, Lynne Ann Barker, Caroline Jordan, Valentina Leta, K. Ray Chaudhuri, Abdul W. Basit, Simon Gaisford. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease. International Journal of Pharmaceutics: X 2021;3:100087
    https://doi.org/10.1016/j.ijpx.2021.100087
  79. Laura E. McCoubrey, Moe Elbadawi, Mine Orlu, Simon Gaisford, Abdul W. Basit. Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 2021;13
    https://doi.org/10.1080/19490976.2021.1872323
  80. Emily Klann, Massimiliano S. Tagliamonte, Maria Ukhanova, Volker Mai, Vinata Vedam-Mai. Gut Microbiota Dynamics in Parkinsonian Mice. ACS Chem. Neurosci. 2020;11:3267
    https://doi.org/10.1021/acschemneuro.0c00386
  81. Tian Zhang, Tan Wang, Xinxu Chen, Zhenqiang Zhao, Zhibin Chen. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons. Exp Ther Med 2021;23
    https://doi.org/10.3892/etm.2021.10974
  82. Nairita Ahsan Faruqui, Durdana Hossain Prium, Sadrina Afrin Mowna, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Umme Salma Zohora, Mohammad Shahedur Rahman. Gut Microorganisms and Neurological Disease Perspectives. Future Neurol. 2021;16
    https://doi.org/10.2217/fnl-2020-0026
  83. Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, Víctor Echeverry-Alzate. Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature. IJMS 2024;25:3010
    https://doi.org/10.3390/ijms25053010
  84. Rochellys Diaz Heijtz, Jonathan Swann. Editorial overview: CNS diseases and the microbiome. Current Opinion in Pharmacology 2019;48:x
    https://doi.org/10.1016/j.coph.2019.09.002
  85. Hui-Fei Lu, Yi-Chi Zhou, Li-Tao Yang, Qian Zhou, Xi-Jia Wang, Shu-Qi Qiu, Bao-Hui Cheng, Xian-Hai Zeng. Involvement and repair of epithelial barrier dysfunction in allergic diseases. Front. Immunol. 2024;15
    https://doi.org/10.3389/fimmu.2024.1348272
  86. Catherine M. Shafer, Ashley Tseng, Patrick Allard, Megan M. McEvoy. Strength of Cu-efflux response in Escherichia coli coordinates metal resistance in Caenorhabditis elegans and contributes to the severity of environmental toxicity. Journal of Biological Chemistry 2021;297:101060
    https://doi.org/10.1016/j.jbc.2021.101060
  87. T.M. Manevich. Intestinal microbiota, pain, dementia. Rus. Jour. of Pain 2022;20:48
    https://doi.org/10.17116/pain20222001148
  88. Bruno Bonnechère, Najaf Amin, Cornelia van Duijn. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review. IJMS 2022;23:13665
    https://doi.org/10.3390/ijms232213665
  89. Christine A. Tataru, Maude M. David, Jacopo Grilli. Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease. PLoS Comput Biol 2020;16:e1007859
    https://doi.org/10.1371/journal.pcbi.1007859
  90. Ajit Kumar Thakur, Nikhila Shekhar, Sakshi Tyagi, Sweta Rani. Nutraceutical Fruits and Foods for Neurodegenerative Disorders. 2020.
    https://doi.org/10.1016/B978-0-443-18951-7.00009-8
  91. Cezmi A. Akdis. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat Rev Immunol 2021;21:739
    https://doi.org/10.1038/s41577-021-00538-7
  92. Xiao-yi Kuai, Xiao-han Yao, Li-juan Xu, Yu-qing Zhou, Li-ping Zhang, Yi Liu, Shao-fang Pei, Chun-li Zhou. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation. Microb Cell Fact 2021;20
    https://doi.org/10.1186/s12934-021-01589-0
  93. A. V. Stavrovskaya, D. N. Voronkov, M. V. Marsova, A. S. Olshansky, A. S. Gushchina, V. N. Danilenko, S. N. Illarioshkin. Effects of the Pharmabiotic U-21 under Conditions of a Combined Neuroinflammatory Model of Parkinson’s Disease in Rats. Bull Exp Biol Med 2024;177:225
    https://doi.org/10.1007/s10517-024-06161-5
  94. Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, Savanah Descôteaux, Maria-Grazia Martinoli. New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection. CPD 2022;28:3068
    https://doi.org/10.2174/1381612828666220919085742
  95. Kathryn A. Chung, Ronald F. Pfeiffer. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77
    https://doi.org/10.1007/s10286-020-00745-7
  96. Amy S. Graham, Benneth Ben-Azu, Marie-Ève Tremblay, Peter Torre, Marjanne Senekal, Barbara Laughton, Andre van der Kouwe, Marcin Jankiewicz, Mamadou Kaba, Martha J. Holmes. A review of the auditory-gut-brain axis. Front. Neurosci. 2023;17
    https://doi.org/10.3389/fnins.2023.1183694
  97. Alpana Singh, Ted M. Dawson, Subhash Kulkarni. Neurodegenerative disorders and gut-brain interactions. 2021;131
    https://doi.org/10.1172/JCI143775
  98. Jessica Eastwood, Gemma Walton, Saskia Van Hemert, Claire Williams, Daniel Lamport. The effect of probiotics on cognitive function across the human lifespan: A systematic review. Neuroscience & Biobehavioral Reviews 2021;128:311
    https://doi.org/10.1016/j.neubiorev.2021.06.032
  99. Alexander Khoruts, Christopher Staley, Michael J. Sadowsky. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 2021;18:67
    https://doi.org/10.1038/s41575-020-0350-4
  100. Ann Liebert, Brian Bicknell, E-Liisa Laakso, Parastoo Jalilitabaei, Sharon Tilley, Hosen Kiat, John Mitrofanis. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19. Photobiomodulation, Photomedicine, and Laser Surgery 2022;40:112
    https://doi.org/10.1089/photob.2021.0056
  101. Leon Fisher, Alexander Fisher, Paul N Smith. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). JCM 2020;9:3253
    https://doi.org/10.3390/jcm9103253
  102. Diego Santos García, Lucía García Roca, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Lucía Naya Ríos, Héctor Canfield, Jose M. Paz González, Cristina Martínez Miró, Silvia Jesús, Miquel Aguilar, Pau Pastor, Lluís Planellas, Marina Cosgaya, Juan García Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernández Vara, Iria Cabo, Lydia López Manzanares, Isabel González Aramburu, Maria A. Ávila Rivera, Víctor Gómez Mayordomo, Víctor Nogueira, Víctor Puente, Julio Dotor García-Soto, Carmen Borrué, Berta Solano Vila, María Álvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo Padilla, Juan C. Martínez Castrillo, Pilar Sánchez Alonso, Maria G. Alonso Losada, Nuria López Ariztegui, Itziar Gastón, Jaime Kulisevsky, Marta Blázquez Estrada, Manuel Seijo, Javier Rúiz Martínez, Caridad Valero, Mónica Kurtis, Oriol de Fábregues, Jessica González Ardura, Ruben Alonso Redondo, Carlos Ordás, Luis M. López Díaz L, Darrian McAfee, Pablo Martinez-Martin, Pablo Mir. Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group. JPD 2022;12:315
    https://doi.org/10.3233/JPD-212868
  103. Nar Singh Chauhan. Comprehensive Gut Microbiota. 2022.
    https://doi.org/10.1016/B978-0-12-819265-8.00025-5
  104. Xinji Liu, Jingjing Zhang, Yanru Sang, Kaiyong Liu, Yitian Zhu, Linsheng Yang, Sufang Wang, Jie Sheng, Qunan Wang, Dongmei Zhang, Hongjuan Cao, Fangbiao Tao. Antibiotic exposure and potential risk of depression in the Chinese elderly: a biomonitoring-based population study. Environ Sci Pollut Res 2021;28:26794
    https://doi.org/10.1007/s11356-021-12560-2